Table 1: Univariate analysis of demographic/comorbidities and mortality of adult patients with Covid-19 at NYU Langone Health from March 3 - May 31 2020 (N = 8324).
|
Risk Factor |
Survivor (N = 7406) |
Expired (N = 918) |
OR (CI) |
P Value |
|
Demographics |
|
|
|
|
|
Female |
3955 (53.4) |
333 (36.3) |
|
|
|
Male |
3451 (46.6) |
585 (63.7) |
2.0 (1.7-2.3) |
< 0.001 |
|
Age (years) |
52.0 ± 17.9 |
73.2 ± 14.0 |
|
< 0.001 |
|
Age > = 60 yo |
2594 (35.0) |
778 (84.7) |
10.3 (8.6-12.4) |
< 0.001 |
|
Age < 60 yo |
4812 (65.0) |
140 (15.3) |
|
< 0.001 |
|
White |
2972 (40.1) |
449 (48.9) |
1.4 (1.2-1.7) |
< 0.001 |
|
Black |
1350 (18.2) |
105 (11.4) |
0.6 (0.5-0.7) |
< 0.001 |
|
Hispanica |
1060 (14.3) |
221 (24.1) |
1.9 (1.6-2.2) |
< 0.001 |
|
Asian |
536 (7.2) |
80 (8.7) |
1.2 (1.0-1.6) |
0.11 |
|
Other Race/Unknown |
2548 (34.4) |
284 (30.9) |
1.0 (0.8-1.1) |
0.71 |
|
Comorbidities |
|
|
|
|
|
BMI (kg/m2) |
29.1 ± 6.8 |
29.2 ± 7.3 |
|
0.71 |
|
Morbid Obesity (BMI > = 35 kg/m2) |
956 (12.9) |
138 (15.0) |
1.2 (1-1.4) |
0.08 |
|
HIV/AIDS |
48 (0.6) |
9 (1.0) |
1.5 (0.7-3.1) |
0.25 |
|
Alcohol Misuse |
110 (1.5) |
22 (2.4) |
1.6 (1-2.6) |
0.04 |
|
Asthma |
701 (9.5) |
97 (10.6) |
1.1 (0.9-1.4) |
0.29 |
|
Anemia |
345 (4.7) |
87 (9.5) |
2.1 (1.7-2.7) |
< 0.001 |
|
Cardiac Arrhythmia |
2144 (28.9) |
795 (86.6) |
15.9 (13-19.3) |
< 0.001 |
|
CHF |
464 (6.3) |
269 (29.3) |
6.2 (5.2-7.4) |
< 0.001 |
|
Cerebrovascular Disease |
378 (5.1) |
149 (16.2) |
3.6 (2.9-4.4) |
< 0.001 |
|
Coagulopathy |
550 (7.4) |
345 (37.6) |
7.5 (6.4-8.8) |
< 0.001 |
|
CPD |
1067 (14.4) |
239 (26.0) |
2.1 (1.8-2.5) |
< 0.001 |
|
Cancerb |
395 (5.3) |
124 (13.5) |
2.8 (2.2-3.4) |
< 0.001 |
|
Hematologic Malignancy |
33 (0.4) |
18 (2.0) |
4.5 (2.5-8) |
< 0.001 |
|
Solid Tumor (without Metastasis) |
321 (4.3) |
95 (10.3) |
2.5 (2-3.2) |
< 0.001 |
|
Lymphoma |
50 (0.7) |
16 (1.7) |
2.6 (1.5-4.6) |
0.001 |
|
Dementia |
270 (3.6) |
139 (15.1) |
4.7 (3.8-5.9) |
< 0.001 |
|
Depression |
641 (8.7) |
137 (14.9) |
1.9 (1.5-2.3) |
< 0.001 |
|
Diabetes with Complications |
566 (7.6) |
243 (26.5) |
4.4 (3.7-5.2) |
< 0.001 |
|
Fluid and Electrolyte Disorders |
2026 (27.4) |
819 (89.2) |
22 (17.7-27.2) |
< 0.001 |
|
HLD |
2067 (27.9) |
564 (61.4) |
4.1 (3.6-4.7) |
< 0.001 |
|
HTN |
2715 (36.7) |
744 (81.0) |
7.4 (6.2-8.8) |
< 0.001 |
|
Hypothyroidism |
600 (8.1) |
139 (15.1) |
2 (1.7-2.5) |
< 0.001 |
|
Liver Disease |
312 (4.2) |
121 (13.2) |
3.5 (2.8-4.3) |
< 0.001 |
|
Myocardial Infarction |
316 (4.3) |
222 (24.2) |
7.2 (5.9-8.6) |
< 0.001 |
|
Neurological Disorder |
613 (8.3) |
381 (41.5) |
7.9 (6.7-9.2) |
< 0.001 |
|
Paralysis |
85 (1.1) |
47 (5.1) |
4.6 (3.2-6.7) |
< 0.001 |
|
Psychoses |
127 (1.7) |
32 (3.5) |
2.1 (1.4-3.1) |
< 0.001 |
|
PUD |
70 (0.9) |
21 (2.3) |
2.5 (1.5-4) |
< 0.001 |
|
Pulmonary Disorders |
334 (4.5) |
203 (22.1) |
6 (5-7.3) |
< 0.001 |
|
PV Disorders |
425 (5.7) |
159 (17.3) |
3.4 (2.8-4.2) |
< 0.001 |
|
Renal Disease |
794 (10.7) |
397 (43.2) |
6.3 (5.5-7.4) |
< 0.001 |
|
Renal Failure |
719 (9.7) |
370 (40.3) |
6.3 (5.4-7.3) |
< 0.001 |
|
Rheumatic Disease |
164 (2.2) |
31 (3.4) |
1.5 (1-2.3) |
0.029 |
|
Smoking |
246 (3.3) |
23 (2.5) |
0.7 (0.5-1.1) |
0.16 |
|
Valvular Heart Disease |
499 (6.7) |
261 (28.4) |
5.5 (4.6-6.5) |
< 0.001 |
Abbreviations: HIV/AIDS: Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome; CHF: Congestive Heart Failure; CPD: Chronic Pulmonary Disease; HLD: Hyperlipidemia; HTN: Hypertension; PUD: Peptic Ulcer Disease; PV: Peripheral Vascular.
aIn the EMR, Hispanic is defined as an ethnicity and can be selected along with any of the options for race. Therefore the number of Hispanic patients overlaps with the number of patients of different racial groups and cannot be used to compute the total number of patients; bCancer does not correspond to the total of solid tumor (non-metastatic), non-solid tumor, and lymphoma as the cancer row only counts the total number of cancer patients, who may have multiple types of cancer.